Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo

Immunity

Volumn 20, Issue 6, 2004, Pages 695-705

  Hawiger, Daniel ^a,d   Masilamani, Revati F ^a   Bettelli, Estelle ^c   Kuchroo, Vijay K ^c   Nussenzweig, Michel C ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; BRAIN DISEASE; CELL ACTIVATION; CLONAL ANERGY; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD5; CELL LINE; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; MICE; MYELIN-ASSOCIATED GLYCOPROTEIN; T-LYMPHOCYTES; TRANSGENES;

EID: 2942523789     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2004.05.002     Document Type: Article

References (74)

1. Adler A.J., Marsh D.W., Yochum G.S., Guzzo J.L., Nigam A., Nelson W.G., Pardoll D.M. CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J. Exp. Med. 187:1998;1555-1564
2. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science. 298:2002;1395-1401
3. Apostolou I., Sarukhan A., Klein L., von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:2002;756-763
4. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:1996;387-396
5. Azzam H.S., Grinberg A., Lui K., Shen H., Shores E.W., Love P.E. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188:1998;2301-2311
6. Azzam H.S., DeJarnette J.B., Huang K., Emmons R., Park C.S., Sommers C.L., El-Khoury D., Shores E.W., Love P.E. Fine tuning of TCR signaling by CD5. J. Immunol. 166:2001;5464-5472
7. Barthlott T., Kassiotis G., Stockinger B. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197:2003;451-460
8. Belz G.T., Behrens G.M., Smith C.M., Miller J.F., Jones C., Lejon K., Fathman C.G., Mueller S.N., Shortman K., Carbone F.R., Heath W.R. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196:2002;1099-1104
9. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197:2003;1073-1081
10. Bhandoola A., Bosselut R., Yu Q., Cowan M.L., Feigenbaum L., Love P.E., Singer A. CD5-mediated inhibition of TCR signaling during intrathymic selection and development does not require the CD5 extracellular domain. Eur. J. Immunol. 32:2002;1811-1817
11. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8(+) T cell tolerance. J. Exp. Med. 196:2002;1627-1638
12. Brossard C., Semichon M., Trautmann A., Bismuth G. CD5 inhibits signaling at the immunological synapse without impairing its formation. J. Immunol. 170:2003;4623-4629
13. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1994;1263-1272
14. Critchfield J.M., Racke M.K., Zuniga-Pflucker J.C., Cannella B., Raine C.S., Goverman J., Lenardo M.J. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science. 263:1994;1139-1143
15. De Smedt T., Pajak B., Muraille E., Lespagnard L., Heinen E., De Baetselier P., Urbain J., Leo O., Moser M. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184:1996;1413-1424
16. Dhodapkar M.V., Steinman R.M. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood. 100:2002;174-177
17. Finkelman F.D., Lees A., Birnbaum R., Gause W.C., Morris S.C. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157:1996;1406-1414
18. Friedman A., Weiner H.L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA. 91:1994;6688-6692
19. Grewal I.S., Foellmer H.G., Grewal K.D., Xu J., Hardardottir F., Baron J.L., Janeway C.A. Jr., Flavell R.A. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science. 273:1996;1864-1867
20. Gross J.A., St John T., Allison J.P. The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. J. Immunol. 144:1990;3201-3210
21. Grossman Z., Paul W.E. Adaptive cellular interactions in the immune system. the tunable activation threshold and the significance of subthreshold responses Proc. Natl. Acad. Sci. USA. 89:1992;10365-10369
22. Grossman Z., Paul W.E. Autoreactivity, dynamic tuning and selectivity. Curr. Opin. Immunol. 13:2001;687-698
23. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:2001;769-779
24. Huang H.J., Jones N.H., Strominger J.L., Herzenberg L.A. Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells. molecular homology to its human counterpart Leu-1/T1 (CD5) Proc. Natl. Acad. Sci. USA. 84:1987;204-208
25. Inaba K., Pack M., Inaba M., Sakuta H., Isdell F., Steinman R.M. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186:1997;665-672
26. Jenkins M.K., Schwartz R.H. Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:1987;302-319
27. Jiang W., Swiggard W.J., Heufler C., Peng M., Mirza A., Steinman R.M., Nussenzweig M.C. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature. 375:1995;151-155
28. Joliat M.J., Lang P.A., Lyons B.L., Burzenski L., Lynes M.A., Yi T., Sundberg J.P., Shultz L.D. Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient "viable motheaten" mice. J. Autoimmun. 18:2002;105-117
29. Jones L.A., Chin L.T., Longo D.L., Kruisbeek A.M. Peripheral clonal elimination of functional T cells. Science. 250:1990;1726-1729
30. Jung S., Unutmaz D., Wong P., Sano G., De los Santos K., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F., et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity. 17:2002;211-220
31. Kappler J.W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 49:1987;273-280
32. Kassiotis G., Zamoyska R., Stockinger B. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J. Exp. Med. 197:2003;1007-1016
33. Kisielow P., Bluthmann H., Staerz U.D., Steinmetz M., von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature. 333:1988;742-746
34. Krummel M.F., Allison J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:1995;459-465
35. Kuchroo V.K., Anderson A.C., Waldner H., Munder M., Bettelli E., Nicholson L.B. T cell response in experimental autoimmune encephalomyelitis (EAE). role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire Annu. Rev. Immunol. 20:2002;101-123
36. Kurts C., Kosaka H., Carbone F.R., Miller J.F., Heath W.R. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J. Exp. Med. 186:1997;239-245
37. Kurts C., Cannarile M., Klebba I., Brocker T. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166:2001;1439-1442
38. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:2001;261-268
39. Legge K.L., Gregg R.K., Maldonado-Lopez R., Li L., Caprio J.C., Moser M., Zaghouani H. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 196:2002;217-227
40. Liu K., Iyoda T., Saternus M., Kimura Y., Inaba K., Steinman R.M. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196:2002;1091-1097
41. Lozano F., Simarro M., Calvo J., Vila J.M., Padilla O., Bowen M.A., Campbell K.S. CD5 signal transduction. positive or negative modulation of antigen receptor signaling Crit. Rev. Immunol. 20:2000;347-358
42. Mahnke K., Guo M., Lee S., Sepulveda H., Swain S.L., Nussenzweig M., Steinman R.M. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151:2000;673-684
43. Matzinger P., Guerder S. Does T-cell tolerance require a dedicated antigen-presenting cell? Nature. 338:1989;74-76
44. McCormack J.E., Callahan J.E., Kappler J., Marrack P.C. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J. Immunol. 150:1993;3785-3792
45. Mendel I., Kerlero de Rosbo N., Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice. fine specificity and T cell receptor V beta expression of encephalitogenic T cells Eur. J. Immunol. 25:1995;1951-1959
46. Menges M., Rossner S., Voigtlander C., Schindler H., Kukutsch N.A., Bogdan C., Erb K., Schuler G., Lutz M.B. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195:2002;15-21
47. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Dal Canto M.C., Bluestone J.A. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:1995;739-745
48. Morgan D.J., Kreuwel H.T., Sherman L.A. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J. Immunol. 163:1999;723-727
49. Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 11:1999;141-151
50. O'Garra A., Barrat F.J. In vitro generation of IL-10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by Th1- and Th2-inducing cytokines. Immunol. Lett. 85:2003;135-139
51. Pape K.A., Merica R., Mondino A., Khoruts A., Jenkins M.K. Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160:1998;4719-4729
52. Perez V.L., Van Parijs L., Biuckians A., Zheng X.X., Strom T.B., Abbas A.K. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 6:1997;411-417
53. Perez-Villar J.J., Whitney G.S., Bowen M.A., Hewgill D.H., Aruffo A.A., Kanner S.B. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway. involvement of SH2-containing phosphotyrosine phosphatase SHP-1 Mol. Cell. Biol. 19:1999;2903-2912
54. Pierre P., Turley S.J., Gatti E., Hull M., Meltzer J., Mirza A., Inaba K., Steinman R.M., Mellman I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature. 388:1997;787-792
55. Probst H.C., Lagnel J., Kollias G., van den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity. 18:2003;713-720
56. Rocha B., von Boehmer H. Peripheral selection of the T cell repertoire. Science. 251:1991;1225-1228
57. Sallusto F., Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189:1999;611-614
58. Scheinecker C., McHugh R., Shevach E.M., Germain R.N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196:2002;1079-1090
59. Schulz O., Reis e Sousa C. Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology. 107:2002;183-189
60. Schwartz R.H. T cell anergy. Annu. Rev. Immunol. 21:2003;305-334
61. Singer G.G., Abbas A.K. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:1994;365-371
62. Singh N.J., Schwartz R.H. The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells. J. Exp. Med. 198:2003;1107-1117
63. Smilek D.E., Gautam A.M., Pearson C., Steinman L., McDevitt H.O. Eae. a model for immune intervention with synthetic peptides Int. Rev. Immunol. 9:1992;223-230
64. Smith K., Seddon B., Purbhoo M.A., Zamoyska R., Fisher A.G., Merkenschlager M. Sensory adaptation in naive peripheral CD4 T cells. J. Exp. Med. 194:2001;1253-1261
65. Spertini F., Stohl W., Ramesh N., Moody C., Geha R.S. Induction of human T cell proliferation by a monoclonal antibody to CD5. J. Immunol. 146:1991;47-52
66. Stamou P., de Jersey J., Carmignac D., Mamalaki C., Kioussis D., Stockinger B. Chronic exposure to low levels of antigen in the periphery causes reversible functional impairment correlating with changes in CD5 levels in monoclonal CD8 T cells. J. Immunol. 171:2003;1278-1284
67. Sun D., Branum K., Sun Q. Prevention of experimental autoimmune encephalomyelitis in Lewis rats by treatment with an anti-rat CD5 antibody (OX19). Cell. Immunol. 145:1992;263-271
68. Tarakhovsky A., Kanner S.B., Hombach J., Ledbetter J.A., Muller W., Killeen N., Rajewsky K. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science. 269:1995;535-537
69. Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:1998;287-296
70. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:1995;541-547
71. Van Parijs L., Ibraghimov A., Abbas A.K. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 4:1996;321-328
72. Verwilghen J., Kingsley G.H., Ceuppens J.L., Panayi G.S. Inhibition of synovial fluid T cell proliferation by anti-CD5 monoclonal antibodies. A potential mechanism for their immunotherapeutic action in vivo. Arthritis Rheum. 35:1992;1445-1451
73. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., Thompson C.B., Bluestone J.A. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:1994;405-413
74. Wong P., Barton G.M., Forbush K.A., Rudensky A.Y. Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands. J. Exp. Med. 193:2001;1179-1187